View in EDS

Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade.

Saved in:
Bibliographic Details
Title: Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade.
Authors: Constantinides A; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands., Lansu N; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and University Medical Center Utrecht, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Mosen P; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, the Netherlands., Rauwerdink P; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgery, Antonius Hospital, Nieuwegein, the Netherlands., Strating E; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands., Völlmy F; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, the Netherlands., Nederend M; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Leusen JHW; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Rovers K; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Wassenaar E; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Lurvink R; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Altelaar M; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, the Netherlands., Nienhuijs S; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Wiezer R; Department of Surgery, Antonius Hospital, Nieuwegein, the Netherlands., Borel Rinkes IHM; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands., Boerma D; Department of Surgery, Antonius Hospital, Nieuwegein, the Netherlands., Kops GJPL; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and University Medical Center Utrecht, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., de Hingh I; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands. Electronic address: ignace.d.hingh@catharinaziekenhuis.nl., Kranenburg O; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Utrecht Platform for Organoid Technology, Utrecht University, Utrecht, the Netherlands. Electronic address: o.kranenburg@umcutrecht.nl.
Source: Translational oncology [Transl Oncol] 2025 Sep; Vol. 59, pp. 102464. Date of Electronic Publication: 2025 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40602034
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Constantinides+A%22">Constantinides A</searchLink>; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lansu+N%22">Lansu N</searchLink>; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and University Medical Center Utrecht, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mosen+P%22">Mosen P</searchLink>; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rauwerdink+P%22">Rauwerdink P</searchLink>; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgery, Antonius Hospital, Nieuwegein, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Strating+E%22">Strating E</searchLink>; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Völlmy+F%22">Völlmy F</searchLink>; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Nederend+M%22">Nederend M</searchLink>; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Leusen+JHW%22">Leusen JHW</searchLink>; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rovers+K%22">Rovers K</searchLink>; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Wassenaar+E%22">Wassenaar E</searchLink>; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lurvink+R%22">Lurvink R</searchLink>; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Altelaar+M%22">Altelaar M</searchLink>; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Nienhuijs+S%22">Nienhuijs S</searchLink>; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Wiezer+R%22">Wiezer R</searchLink>; Department of Surgery, Antonius Hospital, Nieuwegein, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Borel+Rinkes+IHM%22">Borel Rinkes IHM</searchLink>; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Boerma+D%22">Boerma D</searchLink>; Department of Surgery, Antonius Hospital, Nieuwegein, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kops+GJPL%22">Kops GJPL</searchLink>; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), and University Medical Center Utrecht, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Hingh+I%22">de Hingh I</searchLink>; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands. Electronic address: ignace.d.hingh@catharinaziekenhuis.nl.<br /><searchLink fieldCode="AU" term="%22Kranenburg+O%22">Kranenburg O</searchLink>; Laboratory Translational Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Division Imaging and Cancer, University Medical Center Utrecht, Utrecht, the Netherlands; Utrecht Platform for Organoid Technology, Utrecht University, Utrecht, the Netherlands. Electronic address: o.kranenburg@umcutrecht.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101472619%22">Translational oncology</searchLink> [Transl Oncol] 2025 Sep; Vol. 59, pp. 102464. <i>Date of Electronic Publication: </i>2025 Jul 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Neoplasia+Press%22">Neoplasia Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101472619 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1936-5233 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219365233%22">19365233 </searchLink><i>NLM ISO Abbreviation: </i>Transl Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40602034
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.tranon.2025.102464
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102464
    Titles:
      – TitleFull: Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Constantinides A
      – PersonEntity:
          Name:
            NameFull: Lansu N
      – PersonEntity:
          Name:
            NameFull: Mosen P
      – PersonEntity:
          Name:
            NameFull: Rauwerdink P
      – PersonEntity:
          Name:
            NameFull: Strating E
      – PersonEntity:
          Name:
            NameFull: Völlmy F
      – PersonEntity:
          Name:
            NameFull: Nederend M
      – PersonEntity:
          Name:
            NameFull: Leusen JHW
      – PersonEntity:
          Name:
            NameFull: Rovers K
      – PersonEntity:
          Name:
            NameFull: Wassenaar E
      – PersonEntity:
          Name:
            NameFull: Lurvink R
      – PersonEntity:
          Name:
            NameFull: Altelaar M
      – PersonEntity:
          Name:
            NameFull: Nienhuijs S
      – PersonEntity:
          Name:
            NameFull: Wiezer R
      – PersonEntity:
          Name:
            NameFull: Borel Rinkes IHM
      – PersonEntity:
          Name:
            NameFull: Boerma D
      – PersonEntity:
          Name:
            NameFull: Kops GJPL
      – PersonEntity:
          Name:
            NameFull: de Hingh I
      – PersonEntity:
          Name:
            NameFull: Kranenburg O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1936-5233
          Numbering:
            – Type: volume
              Value: 59
          Titles:
            – TitleFull: Translational oncology
              Type: main
ResultId 1